-0.49 | -1.62%
| Price and Volume | |
|---|---|
| Recent Price | 30.34 |
| 52 Week High | 36.48 |
| 52 Week Low | 28.75 |
| Avg. Daily Vol. (Mil) | 0.24 |
| Beta (3 year) | 0.68 |
| Share Related Items | |
| Mkt Cap (Mil) | 5,143.97 |
| Shares Out (Mil) | 169.54 |
| Float (Mil) | 0.00 |
| Dividend Information | |
| Yield % | 0.80 |
| Annual Dividend | 0.23 |
| Payout Ratio | 14.00 |
| Financial Strength | |
| Quick Ratio | 0.90 |
| Current Ratio | 1.40 |
| LT Debt/ Equity | 0.32 |
| Total Debt / Equity | 0.74 |
| Valuation Ratios | |
| Price Earnings | 18.40 |
| Price/Sales | 2.71 |
| Price/Book | 5.26 |
| Price/Cash Flow | 13.20 |
| Per Share Data | |
| Earnings | 1.64 |
| Sales | 11.20 |
| Book Value | 5.77 |
| Cash Flow | 2.30 |
| Business Summary | |
|---|---|
| Dr. Reddy Laboratories, Ltd. produces active pharmaceutical ingredients and intermediates and finished dosage forms and biologics products and markets them globally, with a focus on India, the United States, Europe and Russia. | |
| General Information | |
| 7-1-27 Ameerpet
Hyderabad, An 500016 |
|
| 1.0 | |
| www.drreddys.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 14923 | |
| CEO: Mr. G.V. Prasad | |
| Short Interest | |
| Current Month (Mil) | 0.59 |
| Previous Month (Mil) | 0.98 |
| Short Interest Ratio (Days) | 2.50 |
| Management Effectiveness | |
| Return on Equity | 30.00 |
| Return on Assets | 12.70 |
| Return on Investments | 22.70 |
| Profitability | |
| Gross Margin | 60.60 |
| EBIT Margin | 20.50 |
| Profit Margin | 14.70 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,418.73 | 1,314.04 | 2,831.94 | 16.31 |
Oil *
103.56
|
|
DOWN
161.96 |
DOWN
18.38 |
DOWN
39.05 |
DOWN
1.00 |
10 Yr
1.63%
SPDR Gold
151.80
|
|
-1.29%
|
-1.38%
|
-1.36%
|
-5.78%
|
Data delayed 20 minutes |
Connect with TheStreet